Local Anesthetic Concentration and Nerve Block Duration
NCT ID: NCT03326609
Last Updated: 2018-01-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2017-10-04
2018-01-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Aim: To investigate the effect of LA concentration on peripheral nerve block duration in healthy volunteers.
Methods: Randomization of 60 healthy volunteers who will receive 1 of 5 different volumes of LA (ropivacaine) using a constant dose.
Primary endpoint: Sensory nerve block defined by insensitivity towards cold.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Different Doses (Mass) of Local Anesthetic on Duration of Adductor Canal Block in Healthy Volunteers - Part 2
NCT02172729
The Influence of Lidocaine Volume on Discomfort During Administration of Local Anesthetic
NCT02086292
Effect of Systemic Ropivacaine on Hyperalgesia, Flare Reaction and Peripheral Nerve Excitability
NCT00900913
Intralipid® 20% for Reversal of Local Anesthetics
NCT03968822
The Influence of Injection Speed on Pain During Administration of Local Anaesthetic.
NCT02107742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Important factors for a safe and successful nerve block include volume, dose and concentration of local anesthetic (LA). Knowing the duration of peripheral nerve blocks is important to prevent pain breakthrough. With the advancements in ultrasound (US)-guided nerve block techniques it has been possible to substantially reduce the amount of LA required to perform a successful nerve block. This has reduced the risk of systemic toxicity. However, lowering LA volume may reduce nerve block duration, but the extent of this is sparsely described in a heterogenic study mass.
Diluted and large volumes of LA seem to correlate with nerve block duration. Furthermore, increasing LA concentration seems to increase the level of motor block, but not the block duration. A long-lasting nerve block without dense motor block is preferable for optimized pain control and better opportunities to rehabilitate/ambulate.
Aim:
To investigate the effect of LA concentration on common peroneal nerve block duration in healthy volunteers.
Methods:
Randomization of 60 healthy volunteers who will receive 1 of 5 different volumes of LA (ropivacaine) using a constant dose (10mg).
Primary outcome: Duration of sensory nerve block defined by insensitivity towards cold.
Secondary outcome: Duration of motor nerve block defined by either paresis or paralysis.
Explorative outcomes: Degrees of sensory and motor nerve block; Onset times of sensory and motor nerve block; Length of neural exposure to LA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Volume: 2.5 mL
Perineural injection of ropivacaine 10 mg, 2.5 mL. Concentration: Ropivacaine 4 mg/mL.
Ropivacaine
Perineural injection using a peripheral nerve block catheter and a constant infusion rate (10mL/h)
Volume: 5 mL
Perineural injection of ropivacaine 10 mg, 5 mL. Concentration: Ropivacaine 2 mg/mL
Ropivacaine
Perineural injection using a peripheral nerve block catheter and a constant infusion rate (10mL/h)
Volume: 10 mL
Perineural injection of ropivacaine 10 mg, 10 mL Concentration: Ropivacaine 1 mg/mL
Ropivacaine
Perineural injection using a peripheral nerve block catheter and a constant infusion rate (10mL/h)
Volume: 15 mL
Perineural injection of ropivacaine 10 mg, 15mL Concentration: Ropivacaine 0.67 mg/mL
Ropivacaine
Perineural injection using a peripheral nerve block catheter and a constant infusion rate (10mL/h)
Volume: 20 mL
Perineural injection of ropivacaine 10 mg, 20mL Concentration: Ropivacaine 0.5 mg/mL
Ropivacaine
Perineural injection using a peripheral nerve block catheter and a constant infusion rate (10mL/h)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ropivacaine
Perineural injection using a peripheral nerve block catheter and a constant infusion rate (10mL/h)
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. ASA classification ≤ II
Exclusion Criteria
2. Former surgery to the lower extremity in which intervention is planned and surgery which may have caused neural damage to the common peroneal nerve/affected the sensory distribution area of the common peroneal nerve
3. Peripheral nerve disease
4. Allergy to LA
5. Pregnancy or breastfeeding
6. Enrolment in other investigational drug studies or recent clinical trials that may interfere with this study
7. Habitual use of any kind of analgesic treatment
8. Anatomic abnormalities preventing successful US-guided peripheral nerve catheter insertion
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovation Fund Denmark
INDIV
Nordsjaellands Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claus Behrend Christiansen
Medical doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claus B Christiansen, MD
Role: PRINCIPAL_INVESTIGATOR
Nordsjaellands Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nordsjællands Hospital
Hillerød, Danmark, Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Christiansen CB, Madsen MH, Molleskov E, Rothe C, Lundstrom LH, Lange KHW. The effect of ropivacaine concentration on common peroneal nerve block duration using a fixed dose: A randomised, double-blind trial in healthy volunteers. Eur J Anaesthesiol. 2020 Apr;37(4):316-322. doi: 10.1097/EJA.0000000000001112.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-17022555
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.